Journal of Antimicrobial Chemotherapy, Vol 40, 889-893, Copyright © 1997 by The British Society for Antimicrobial Chemotherapy
A De Logu, AM Fadda, C Anchisi, AM Maccioni, C Sinico, ML Schivo and F Alhaique
Antifungal agents are often used in liposomal formulations in order to
improve their pharmacological activity, but how vesicle inclusion can
actually affect this is still not fully understood. We report here the
results obtained from evaluation of the in-vitro activity against Candida
albicans ATCC E10231 of miconazole and ketoconazole in various vesicular
and non-vesicular preparations, obtained from egg and soya phospholipids,
using time-kill curves. In most cases inclusion of miconazole or
ketoconazole in liposomes led to a delayed and decreased activity of the
drugs, with detectable differences among the various phospholipid
concentrations and different liposomal preparations (small unilamellar
vesicle, liposomes, multilamellar aggregates and broken liposomal
structures). The results obtained may be helpful in the study of new
preparations of antifungal agents entrapped in liposomal structures.
ORIGINAL ARTICLES
Effects of in-vitro activity of miconazole and ketoconazole in phospholipid formulations
Dipartimento di Scienze Chirurgiche e Trapianti d'Organo, Universita degli Studi di Cagliari, Italy. adelogu@vaxca1.unica.it
![]()
CiteULike
Connotea
Del.icio.us What's this?